Vijay Kumar
Stock Analyst at Evercore ISI Group
(2.19)
# 2,767
Out of 4,924 analysts
231
Total ratings
39.39%
Success rate
-4.42%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AZTA Azenta | Maintains: In-Line | $35 → $33 | $28.65 | +15.18% | 8 | Aug 5, 2025 | |
| MTD Mettler-Toledo International | Maintains: Outperform | $1,280 → $1,275 | $1,236.26 | +3.13% | 11 | Aug 4, 2025 | |
| AVTR Avantor | Maintains: Outperform | $18 → $16 | $11.45 | +39.74% | 11 | Aug 4, 2025 | |
| EW Edwards Lifesciences | Maintains: In-Line | $77 → $80 | $78.38 | +2.07% | 13 | Jul 25, 2025 | |
| CAI Caris Life Sciences | Initiates: Outperform | $33 | $28.88 | +14.27% | 1 | Jul 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: In-Line | $102 → $96 | $90.94 | +5.56% | 13 | Jul 8, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $500 → $480 | $457.00 | +5.03% | 12 | Jul 8, 2025 | |
| SYK Stryker | Maintains: Outperform | $390 → $415 | $376.93 | +10.10% | 11 | Jul 8, 2025 | |
| RVTY Revvity | Maintains: Outperform | $116 → $115 | $87.25 | +31.81% | 2 | Jul 8, 2025 | |
| MDT Medtronic | Maintains: Outperform | $103 → $106 | $89.74 | +18.12% | 5 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $470 → $550 | $479.74 | +14.65% | 13 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $116 → $128 | $95.44 | +34.12% | 7 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $62 → $68 | $67.82 | +0.27% | 15 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $66 → $68 | $46.81 | +45.27% | 5 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $46 | $26.13 | +76.04% | 4 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $226 | $197.67 | +14.33% | 3 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $16 → $16 | $14.26 | +12.24% | 9 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $44 → $42 | $22.63 | +85.59% | 7 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $140 → $145 | $131.65 | +10.14% | 11 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $125 → $130 | $114.21 | +13.83% | 4 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $44 → $49 | $44.71 | +9.60% | 6 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $3 | $3.00 | +0.17% | 6 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $96 → $85 | $70.46 | +20.64% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $110 → $112 | $104.44 | +7.24% | 6 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $207 → $202 | $143.70 | +40.58% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $18 → $30 | $11.38 | +163.74% | 11 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $335 → $355 | $279.68 | +26.93% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $56 | $26.55 | +110.92% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $58.11 | +175.34% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $176.03 | +64.74% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $1.18 | +493.22% | 1 | May 31, 2022 |
Azenta
Aug 5, 2025
Maintains: In-Line
Price Target: $35 → $33
Current: $28.65
Upside: +15.18%
Mettler-Toledo International
Aug 4, 2025
Maintains: Outperform
Price Target: $1,280 → $1,275
Current: $1,236.26
Upside: +3.13%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $18 → $16
Current: $11.45
Upside: +39.74%
Edwards Lifesciences
Jul 25, 2025
Maintains: In-Line
Price Target: $77 → $80
Current: $78.38
Upside: +2.07%
Caris Life Sciences
Jul 15, 2025
Initiates: Outperform
Price Target: $33
Current: $28.88
Upside: +14.27%
Zimmer Biomet Holdings
Jul 8, 2025
Maintains: In-Line
Price Target: $102 → $96
Current: $90.94
Upside: +5.56%
Thermo Fisher Scientific
Jul 8, 2025
Maintains: Outperform
Price Target: $500 → $480
Current: $457.00
Upside: +5.03%
Stryker
Jul 8, 2025
Maintains: Outperform
Price Target: $390 → $415
Current: $376.93
Upside: +10.10%
Revvity
Jul 8, 2025
Maintains: Outperform
Price Target: $116 → $115
Current: $87.25
Upside: +31.81%
Medtronic
Jul 8, 2025
Maintains: Outperform
Price Target: $103 → $106
Current: $89.74
Upside: +18.12%
Jul 8, 2025
Maintains: In-Line
Price Target: $470 → $550
Current: $479.74
Upside: +14.65%
Jul 8, 2025
Maintains: Outperform
Price Target: $116 → $128
Current: $95.44
Upside: +34.12%
Jul 8, 2025
Maintains: In-Line
Price Target: $62 → $68
Current: $67.82
Upside: +0.27%
Jul 8, 2025
Maintains: Outperform
Price Target: $66 → $68
Current: $46.81
Upside: +45.27%
Jul 8, 2025
Maintains: Outperform
Price Target: $48 → $46
Current: $26.13
Upside: +76.04%
Jul 8, 2025
Maintains: Outperform
Price Target: $230 → $226
Current: $197.67
Upside: +14.33%
Jul 8, 2025
Maintains: Outperform
Price Target: $16 → $16
Current: $14.26
Upside: +12.24%
Jul 8, 2025
Maintains: Outperform
Price Target: $44 → $42
Current: $22.63
Upside: +85.59%
Jul 8, 2025
Maintains: Outperform
Price Target: $140 → $145
Current: $131.65
Upside: +10.14%
Jul 8, 2025
Maintains: In-Line
Price Target: $125 → $130
Current: $114.21
Upside: +13.83%
Jun 4, 2025
Maintains: In-Line
Price Target: $44 → $49
Current: $44.71
Upside: +9.60%
May 19, 2025
Maintains: In-Line
Price Target: $3
Current: $3.00
Upside: +0.17%
May 1, 2025
Maintains: Outperform
Price Target: $96 → $85
Current: $70.46
Upside: +20.64%
Apr 24, 2025
Maintains: Outperform
Price Target: $110 → $112
Current: $104.44
Upside: +7.24%
Jan 17, 2025
Maintains: Outperform
Price Target: $207 → $202
Current: $143.70
Upside: +40.58%
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $11.38
Upside: +163.74%
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $279.68
Upside: +26.93%
Oct 1, 2024
Maintains: Outperform
Price Target: $52 → $56
Current: $26.55
Upside: +110.92%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $58.11
Upside: +175.34%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $176.03
Upside: +64.74%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $1.18
Upside: +493.22%